The ratio of Firmicutes to Bacteroidetes in the gut microbiota of patients with type 2 diabetes is altered to absorb higher energy for insulin resistance (45, 46); Regulating the content of glucagon and insulin in blood can also improve lipid metabolism disorder and intestinal flora structure, effectively preventing and treating type 2 diabetes (99). The gene discussed is INS; the disease is type 2 diabetes mellitus.